Ticker > Company >

Trident Lifeline share price

Trident Lifeline Ltd.

BSE: 543616 SECTOR: Pharmaceuticals & Drugs  25k   60   4

267.00
+14.35 (5.68%)
BSE: Today, 04:01 PM

Price Summary

Today's High

₹ 273

Today's Low

₹ 254

52 Week High

₹ 339

52 Week Low

₹ 140.05

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationExpensive
The stock is at a premium valuation at this point.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

307.03 Cr.

Enterprise Value

307.21 Cr.

No. of Shares

1.15 Cr.

P/E

43.59

P/B

4.95

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  53.99

CASH

6.01 Cr.

DEBT

6.2 Cr.

Promoter Holding

62.99 %

EPS (TTM)

₹  6.13

Sales Growth

40.89%

ROE

14.34 %

ROCE

19.11%

Profit Growth

17.16 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year40.89%
3 Year66.8%
5 YearNA

Profit Growth

1 Year17.16%
3 Year123.33%
5 YearNA

ROE%

1 Year14.34%
3 Year73.87%
5 Year44.32%

ROCE %

1 Year19.11%
3 Year33.11%
5 Year24.8%

Debt/Equity

0.1177

Price to Cash Flow

342.93

Interest Cover Ratio

20.3618

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Dec 2024 62.99 3.46
Sep 2024 62.99 0.00
Jun 2024 65.51 0.00
Mar 2024 67.48 1.76
Dec 2023 70.04 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 123.333080882057% for the Past 3 years.
  • The company has shown a good revenue growth of 66.7963012999551% for the Past 3 years.
  • Company has been maintaining healthy ROE of 73.8690322880373% over the past 3 years.
  • Company has been maintaining healthy ROCE of 33.1111348887018% over the past 3 years.
  • Company has a healthy Interest coverage ratio of 20.3618.
  • Company has a healthy liquidity position with current ratio of 3.0501.
  • The company has a high promoter holding of 62.99%.

 Limitations

  • Promoter pledging has increased from 0% to 3.46% in 1 quarter.

Quarterly Result (All Figures in Cr.)

PARTICULARS Mar 2023 Jun 2023 Jun 2024 Sep 2024 Dec 2024
Net Sales 8.46 8.64 14.74 15.66 16.51
Total Expenditure 6.51 6.88 10.66 11.24 12.37
Operating Profit 1.95 1.76 4.08 4.42 4.14
Other Income 0.63 0.33 0.47 0.52 0.54
Interest 0.15 0.1 0.2 0.27 0.35
Depreciation 0.12 0.13 0.33 0.16 0.38
Exceptional Items 0 0 0 0 0
Profit Before Tax 2.31 1.86 4.02 4.52 3.95
Tax 0.34 0.46 1.01 1.13 0.92
Profit After Tax 1.98 1.4 3.01 3.39 3.03
Adjusted EPS (Rs) 1.72 1.22 2.62 2.95 2.63

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 4.93 9.62 21.77 31.69 44.65
Total Expenditure 5.2 8.37 19.06 25.43 35.78
Operating Profit -0.27 1.25 2.71 6.27 8.87
Other Income 0.07 0.16 0.6 1.15 2.2
Interest 0.76 0.41 0.13 0.48 0.51
Depreciation 0.12 0.14 0.2 0.36 0.77
Exceptional Items 0 0 0 0 0
Profit Before Tax -1.08 0.85 2.98 6.57 9.8
Tax -0.28 0.22 -0.96 0.56 2.76
Net Profit -0.8 0.63 3.95 6.01 7.04
Adjusted EPS (Rs.) -2.57 1.26 4.93 5.23 6.13

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3.1 5 8 11.5 11.5
Total Reserves -6.1 -5.47 -3.22 34.13 41.18
Borrowings 6.46 4.53 1.42 0.46 3.58
Other N/C liabilities -2.01 -1.79 -0.97 -0.45 -0.08
Current liabilities 2.87 7.34 7.61 10.67 17.59
Total Liabilities 4.32 9.6 12.84 56.31 73.78
Assets
Net Block 0.77 1.18 1.43 3.11 7.62
Capital WIP 0 0 0 0.23 4.03
Intangible WIP 0 0 0 0 0
Investments 0 0 0.05 4.04 4.4
Loans & Advances 0.73 0.68 0.67 0.71 4.04
Other N/C Assets 0 0 0 0.03 0.02
Current Assets 2.83 7.74 10.69 48.18 53.67
Total Assets 4.32 9.6 12.84 56.31 73.78
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations -1.08 0.85 2.98 6.57 9.8
Adjustment 0.88 0.55 0.33 0.08 -0.53
Changes in Assets & Liabilities -0.4 0.08 -3.65 -22.72 -5.99
Tax Paid 0 0 0 -0.54 -2.38
Operating Cash Flow -0.59 1.48 -0.19 -16.6 0.9
Investing Cash Flow -0.08 -0.56 -0.5 -5.56 -11.01
Financing Cash Flow 0.76 -0.96 0.8 35.8 2.35
Net Cash Flow 0.08 -0.03 0.11 13.64 -7.76

Corporate Actions

Investors Details

PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024% Dec 2024%
promoters 70.04 67.48 65.51 62.99 62.99
amit bhupendra halvawala 1.19 1.19 1.19 1.19 1.19
anjanaben jigishkumar des... 7.03 7.03 7.03 7.03 7.03
hardik jigishkumar desai 21.85 21.85 22.05 23.50 23.50
hardik jigishkumar desai,... 4.67 4.90 5.47 5.52 5.52
mayurkumar mansukhbhai ga... 7.61 5.63 4.13 4.13 4.13
mohak gajera 4.13 4.13 4.13 4.13 4.13
niyati roshan thakkar 1.05 1.05 1.05 1.05 1.05
rinkal mayurbhai gajera 8.04 8.04 6.80 4.13 4.13
rupaben chetanbhai jariwa... 5.84 5.84 5.84 5.84 5.84
tarang nathabhai gajera 6.66 5.84 5.84 5.84 5.84
trident texofab limited 1.98 1.98 - 0.64 0.64
trident texofab - - 1.98 - -
PARTICULARS Dec 2023% Mar 2024% Jun 2024% Sep 2024% Dec 2024%
investors 29.96 32.52 34.49 37.01 37.01
axita industries private ... 1.02 1.02 1.02 1.02 1.02
chetan muktilal mehta huf... - 1.05 1.05 1.05 1.05
goenka business and finan... 5.69 4.75 4.65 4.30 4.22
llp - 0.05 - 0.01 0.01
nav capital vcc - nav cap... 4.64 6.02 6.02 6.01 6.01

Annual Reports

No Annual reports exist for this company.Report us

Ratings & Research Reports

No Credit and Research reports exist for this company.Report us

Company Presentations

Company News

Trident Lifeline partners with National Institutes of Pharmaceutical Education and Research- Ahmedabad 6 Mar, 3:40 PM Trident Lifeline - Quaterly Results 22 Jan, 5:41 PM Trident Lifeline - Quaterly Results 22 Jan, 5:41 PM Trident Lifeline - Quaterly Results 22 Jan, 5:41 PM Trident Lifeline completes acquisition of 50.49% stake in TLL Parenterals 3 Dec, 11:57 AM Trident Lifeline informs about investor presentation 25 Oct, 4:26 PM Trident Lifeline - Quaterly Results 19 Oct, 6:01 PM Trident Lifeline - Quaterly Results 19 Oct, 6:01 PM Trident Lifeline informs about disclosure 28 Sep, 3:27 PM Trident Lifeline informs about disclosure 13 Sep, 5:04 PM Trident Lifeline commences commercial production at manufacturing plant in Surat 13 Sep, 9:39 AM Trident Lifeline informs about disclosure 4 Sep, 12:49 PM Trident Lifeline informs about disclosure 29 Aug, 11:15 AM Trident Lifeline informs about disclosure 29 Aug, 11:14 AM Trident Lifeline informs about disclosure 26 Aug, 5:07 PM Trident Lifeline informs about disclosure 26 Aug, 3:06 PM Trident Lifeline informs about disclosure 23 Aug, 2:50 PM Trident Lifeline informs about disclosure 8 Aug, 10:57 AM Trident Lifeline informs about disclosures 27 Jul, 3:59 PM Trident Lifeline informs about disclosures 27 Jul, 3:56 PM Trident Lifeline informs about disclosures 27 Jul, 3:48 PM Trident Lifeline informs about disclosures 27 Jul, 3:36 PM Trident Lifeline informs about disclosure 25 Jul, 11:03 AM Trident Lifeline - Quaterly Results 17 Jul, 3:44 PM Trident Lifeline - Quaterly Results 17 Jul, 3:44 PM Trident Lifeline - Quaterly Results 17 Jul, 3:44 PM Trident Lifeline informs about disclosure 21 May, 2:11 PM Trident Lifeline informs about disclosures 18 May, 3:05 PM Trident Lifeline informs about disclosure 9 May, 12:15 PM Trident Lifeline’s arm commissions manufacturing facilities at Surat 26 Apr, 3:12 PM Trident Lifeline gets nod to incorporate wholly owned subsidiary 8 Apr, 9:50 AM Trident Lifeline informs about press release 28 Mar, 3:16 PM Trident Lifeline informs about disclosure 22 Mar, 3:24 PM Trident Lifeline informs about disclosure 21 Mar, 10:45 AM Trident Lifeline informs about disclosure 19 Mar, 5:13 PM Trident Lifeline informs about disclosures 13 Mar, 5:09 PM Trident Lifeline informs about disclosures 2 Mar, 4:23 PM Trident Lifeline informs about disclosure 26 Feb, 5:27 PM Trident Lifeline informs about disclosure 17 Feb, 3:38 PM Trident Lifeline informs about disclosure 16 Feb, 5:06 PM Trident Lifeline informs about disclosure 16 Feb, 4:40 PM Trident Lifeline informs about updates on acquisition 15 Dec, 4:46 PM Trident Lifeline informs about acquisition 11 Dec, 3:43 PM Trident Lifeline gets nod to acquire 51% stake in TLL Parenterals 11 Dec, 2:51 PM Trident Lifeline informs about newspaper advertisements 24 Aug, 5:13 PM Trident Lifeline completes acquisition of 51% stake in TLL Herbal 10 Aug, 12:20 PM Trident Lifeline completes acquisition of 18% stake in Tricorp Industries 26 Jul, 2:40 PM Trident Lifeline informs about acquisition 26 Jul, 2:25 PM Trident Lifeline gets nod to acquire 51% stake in TLL Herbal 17 Jul, 9:24 AM Trident Lifeline - Quaterly Results 15 Jul, 7:17 PM

Trident Lifeline Stock Price Analysis and Quick Research Report. Is Trident Lifeline an attractive stock to invest in?

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Trident Lifeline and its performance over the period of time. Trident Lifeline stock price today is Rs 267.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Trident Lifeline cash from the operating activity was Rs 0.8953 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Trident Lifeline has a Debt to Equity ratio of 0.1177 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Trident Lifeline , the EPS growth was 17.155 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Trident Lifeline has OPM of 19.8706004604456 % which is a good sign for profitability.
     
  • ROE: Trident Lifeline have a average ROE of 14.3376 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Trident Lifeline is Rs 267. One can use valuation calculators of ticker to know if Trident Lifeline share price is undervalued or overvalued.
Last Updated on:
Brief about Trident Lifeline
X